➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
AstraZeneca
Baxter
Boehringer Ingelheim
Colorcon

Last Updated: July 30, 2021

DrugPatentWatch Database Preview

Details for Patent: 9,597,289


Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,597,289 protect, and when does it expire?

Patent 9,597,289 protects FLOLIPID and is included in one NDA.

This patent has twelve patent family members in twelve countries.

Summary for Patent: 9,597,289
Title:Liquid oral simvastatin compositions
Abstract: A suspension which is suitable for oral administration, comprising simvastatin, at least one suspending agent, and at least one preservative, wherein at least 90 wt % of the particles of simvastatin are less than 100 .mu.m in diameter. The present invention also includes uses of the suspension and methods of making the suspension.
Inventor(s): Driver; Phillip (Keighley, GB)
Assignee: ROSEMONT PHARMACEUTICALS LTD. (Leeds, GB)
Application Number:12/298,451
Patent Claim Types:
see list of patent claims
Compound; Dosage form;

Drugs Protected by US Patent 9,597,289

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Tcg Fluent Pharma FLOLIPID simvastatin SUSPENSION;ORAL 206679-001 Apr 21, 2016 RX Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
Tcg Fluent Pharma FLOLIPID simvastatin SUSPENSION;ORAL 206679-002 Apr 21, 2016 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,597,289

PCT Information
PCT FiledApril 26, 2007PCT Application Number:PCT/GB2007/001552
PCT Publication Date:November 08, 2007PCT Publication Number: WO2007/125339

International Family Members for US Patent 9,597,289

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 552825 ⤷  Free Forever Trial
Australia 2007245410 ⤷  Free Forever Trial
China 101431982 ⤷  Free Forever Trial
Cyprus 1112917 ⤷  Free Forever Trial
Denmark 2018153 ⤷  Free Forever Trial
European Patent Office 2018153 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
McKinsey
Moodys
Harvard Business School
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.